Biodesix, Inc. (BDSX) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Biodesix, Inc., a Delaware corporation, on September 12, 2025. The report details corporate governance actions taken to modify the rights of security holders, specifically regarding the company's capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural changes rather than financial performance metrics.
Material Changes
- Reverse Stock Split: Effective September 15, 2025, at 12:01 a.m. Eastern Time, the Company effected a one-for-twenty reverse stock split of its common stock. This action was approved by stockholders on May 20, 2025, and finalized by the Board on September 4, 2025.
- Trading Adjustments: Common stock began trading on a split-adjusted basis under a new CUSIP number (09075X207). No fractional shares were issued; instead, stockholders entitled to fractional shares received cash based on the closing price on the last trading day prior to the effective date.
- Preferred Stock Elimination: On September 12, 2025, the Company filed a Certificate of Elimination with the Delaware Secretary of State, effectively eliminating all provisions related to the Series A Non-Voting Convertible Preferred Stock previously designated on April 8, 2024.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the standard incorporation by reference of the full text of the Reverse Split Amendment and Certificate of Elimination. The primary operational impact is the reduction in the number of outstanding shares and the removal of the Series A preferred stock class.
Investor Verification Checklist
- Verify the new CUSIP number (09075X207) for trading purposes.
- Confirm the cash settlement amount for any fractional shares held prior to the September 15, 2025 effective date.
- Review the impact of the 1:20 reverse split on share ownership percentages and per-share metrics.
- Confirm the complete elimination of Series A Non-Voting Convertible Preferred Stock rights and obligations.